MRK · News · 20260908N

Guidance and Outlook

Merck & Co., Inc. · 2026-09-08 · Importance 32 · Surprise 24

Merck reaffirmed its fiscal 2026 EPS guidance, according to third-party reporting. Analysts cited quarterly revenue of $16.61 billion, up 5.1% year over year, as supporting the outlook. The company is scheduled to discuss its outlook at the Morgan Stanley 24th Annual Global Healthcare Conference on September 9, 2026.

Key facts

• Merck to participate in the Morgan Stanley 24th Annual Global Healthcare Conference (announced 2026-09-08). source
• Analysts anticipate Merck to achieve $2.76 in EPS for the current fiscal year (analyst expectation cited alongside Merck's results). source